Transforming Growth Factor α Expression Drives Constitutive Epidermal Growth Factor Receptor Pathway Activation and Sensitivity to Gefitinib (Iressa) in Human Pancreatic Cancer Cell Lines (vol 66, pg 3802, 2006)

被引：0
|
作者：
Nawrocki, S. T.
Carew, J. S.
Pino, M. S.
Highshaw, R. A.
Dunner, K., Jr.
Huang, P.
Abbruzzese, J. L.
McConkey, D. J.
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷 / 02期
关键词：
D O I：
10.1158/0008-5472.CAN-09-4221
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：852 / U1
页数：2
相关论文
共 50 条
  • [31] Epidermal Growth Factor Induces Cell Death in the Absence of Overexpressed Epidermal Growth Factor Receptor and ErbB2 in Various Human Cancer Cell Lines
    Choi, Jene
    Moon, Soo Young
    Hong, Joon Pio
    Song, Ji-young
    Oh, Kyung Taek
    Lee, Sang-wook
    CANCER INVESTIGATION, 2010, 28 (05) : 505 - 514
  • [32] EXPRESSION OF THE TRANSFORMING GROWTH FACTOR-ALPHA EPIDERMAL GROWTH-FACTOR RECEPTOR PATHWAY IN NORMAL HUMAN-BREAST EPITHELIAL-CELLS
    BATES, SE
    VALVERIUS, EM
    ENNIS, BW
    BRONZERT, DA
    SHERIDAN, JP
    STAMPFER, MR
    MENDELSOHN, J
    LIPPMAN, ME
    DICKSON, RB
    ENDOCRINOLOGY, 1990, 126 (01) : 596 - 607
  • [33] Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines
    Dahiya, R
    Lee, C
    Haughney, PC
    Chui, R
    Ho, R
    Deng, GR
    UROLOGY, 1996, 48 (06) : 963 - 970
  • [34] GENOMIC SIGNATURE CORRELATING SENSITIVITY OF BLADDER CANCER CELL LINES TO EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS
    Levin, Trevor
    Korkola, Jim
    Liby, Tiera
    LaRochelle, Jeffery
    Anderson, Ross
    McNamara, Steven
    Amling, Christopher
    Gray, Joe
    Koppie, Theresa
    JOURNAL OF UROLOGY, 2013, 189 (04): : E383 - E383
  • [35] Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway (vol 283, pg 31736, 2008)
    Bergin, David A.
    Greene, Catherine M.
    Sterchi, Erwin E.
    Kenna, Cliona
    Geraghty, Patrick
    Belaaouaj, Abderrazzaq
    Taggart, Clifford C.
    O'Neill, Shane J.
    McElvaney, Noel G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (14) : 9624 - 9624
  • [36] Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines
    Pino, Maria S.
    Balsamo, Michele
    Di Modugno, Francesca
    Mottolese, Marcella
    Alessio, Massimo
    Melucci, Elisa
    Milella, Michele
    McConkey, David J.
    Philippar, Ulrike
    Gertler, Frank B.
    Natali, Pier Giorgio
    Nistico, Paola
    CLINICAL CANCER RESEARCH, 2008, 14 (15) : 4943 - 4950
  • [37] Activity of the epidermal growth factor receptor inhibitor gefitinib ('Iressa', ZD1839) in refractory non-small-cell lung cancer
    Parra, HS
    Cavina, R
    Zucali, P
    Campagnoli, E
    Latteri, F
    Biancofiore, G
    Abbadessa, G
    Morenghi, E
    Santoro, A
    BRITISH JOURNAL OF CANCER, 2003, 89 : S33 - S33
  • [38] Elucidating the Mechanism of Regulation of Transforming Growth Factor β Type II Receptor Expression in Human Lung Cancer Cell Lines
    Halder, Sunil K.
    Cho, Yong-Jig
    Datta, Arunima
    Anumanthan, Govindaraj
    Ham, Amy-Joan L.
    Carbone, David P.
    Datta, Pran K.
    NEOPLASIA, 2011, 13 (10): : 912 - U56
  • [39] Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese
    Uramoto, H
    Sugio, K
    Oyama, T
    Ono, K
    Sugaya, M
    Yoshimatsu, T
    Hanagiri, T
    Morita, M
    Yasumoto, K
    LUNG CANCER, 2006, 51 (01) : 71 - 77
  • [40] EXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN SMALL-CELL LUNG-CANCER CELL-LINES
    DAMSTRUP, L
    RYGAARD, K
    SPANGTHOMSEN, M
    POULSEN, HS
    CANCER RESEARCH, 1992, 52 (11) : 3089 - 3093
12345